Resistance to antibiotics used in dermatological practice

British Journal of Dermatology, Supplement

Volumn 139, Issue 53, 1998, Pages 4-8

  Espersen, F ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE; CLINDAMYCIN; ERYTHROMYCIN; FUSIDIC ACID; METICILLIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL SKIN DISEASE; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; ORAL DRUG ADMINISTRATION; PENICILLIN RESISTANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS GROUP A;

EID: 0032437216     PISSN: 0366077X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.1390s3004.x     Document Type: Review

References (27)

1. Kunin CM. Resistance to antimicrobial drugs - a worldwide calamity. Ann Intern Med 1993; 118: 557-61.
2. Neu HC. The crisis in antibacterial resistance. Science 1992; 257: 1064-73.
3. Travis J. Reviving the antibiotic miracle? Science 1994; 264: 360-2.
4. Wessels JC, Koeleman HA, Steyn HS, Ellis SM. The application of new bioavailability parameters in the bioequivalence testing of antimicrobial agents. Int J Clin Pharmacol Ther Toxicol 1993; 11: 542-6.
5. Hostetler KY, Hall LB. Inhibition of kidney lysosomal phospholipases A and C by aminoglycoside antibiotics: possible mechanism of aminoglycoside toxicity. Proc Natl Acad Sci USA 1982; 79: 1663-7.
6. Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science 1994; 264: 375-81.
7. Spratt BG. Resistance to antibiotics mediated by target alterations. Science 1994; 264: 375-82.
8. Georgopapadakou NH, Dix BA, Mauriz YR. Binding of beta-lactam antibiotics to penicillin-binding proteins in a Staphylococcus aureus and Streptococcus faecalis. relation to antibacterial activity. Antimicrob agents Chemother 1986; 29: 333-6.
9. Chambers HF. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microb Rev 1997; 10: 781-91.
10. Leclercq R, Dutka-Malen S, Brisson-Noel A et al. Resistance of enterococci to aminoglycosides and glycopeptides. Clin Infect Dis 1992; 15: 495-501.
11. Volker TA, Iida S, Bickle TA. A single gene coding for resistance to both fusidic acid and chloramphenicol. J Mol Biol 1982; 154: 417-25.
12. Drlica K, Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev 1997; 61: 377-92.
13. Sanders CC, Sanders WE Jr. Beta-lactam resistance in Gram-negative bacteria: Global trends and clinical impact Clin Infect Dis 1992; 15: 824-39.
14. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for betalactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995; 39: 1211-33.
15. Espersen F, Rosdahl VT, Frimodt-Møller N, Skinhøj P. Epidemiology of Staphylococcus aureus bacteremia in Denmark. J Chemother 1994; 6: 219-25.
16. Menard R, Molinas C, Arthur M et al. Overproduction of 3′-aminoglycoside phosphotransferase type I confers resistance to tobramycin in Escherichia coli. Antimicrob Agents Chemother 1993; 37: 78-83.
17. Mendez B, Tachibana C, Levy SB. Heterogeneity of tetracycline resistance determinants. Plasmid 1980; 3: 99-108.
18. Boyce JM. Patterns of methicillin-resistant Staphylococcus aureus prevalence. Infect Control Hosp Epidemiol 1991; 12: 79-82.
19. Jarløv JO, Højbjerg T, Busch-Sørensen C et al. Coagulase-negative staphylococci in Danish blood cultures: species distribution and antibiotic susceptibility. J Hosp Infect 1996; 32: 217-27.
20. Moellering RG Jr. The enterococci: a classic example of the impact of antimicrobial resistance on therapeutic options. J Antimicrob Chemother 1991; 28: 1-12.
21. Hiramatsu K, Aritaka N, Hanaki H et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997; 350: 1670-3.
22. Westh H, Hougaard D, Vuust J, Rosdahl VT. Prevalence of erm gene classes in erythromycin-resistant Staphylococcus aureus strains isolated between 1959 and 1988. Antimicrob Agents Chemother 1995; 39: 369-373.
23. Roberts MC. Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution. FEMS Microb Rev 1996; 19: 1-24.
24. Eady EA, Bojar RA, Jones CE et al. The effect of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria. Br J Dermatol 1996; 134: 107-13.
25. Friis H, Bro F, Eriksen NR et al. The effect of reimbursement on the use of antibiotics. Scand J Prim Health Care 1993; 11: 247-51.
26. Aarestrup FM, Ahrens P, Madsen M et al. Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes with vanA cluster. Antimicrobial Agents Chemother 1996; 40: 1938-40.
27. Faber M, Rosdahl VT. Susceptibility to fusidic acid among Danish Staphylococcus aureus strains and fusidic acid consumption. J Antimicrob Chemother 1990; 25 (Suppl. B): 7-14.